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Upper Respiratory Tract Infections (URTIs) include rhi-
nosinusitis, acute otitis media (AOM), pharyngotonsillitis
and laryngitis [1]. Viruses are responsible for the great
majority of URTIs therefore antimicrobial treatment is
not always required [2]. Paracetamol (7-15 mg/kg/dose)
and ibuprofen (4-10 mg/kg/dose) are considered as the
standard analgesics [3].
Regarding rhinosinusitis, clinicians should suspect a
bacterial etiology when a child presents with persistent,
worsening or severe illness. S. pneumoniae, H. influenzae
and M. catarrhalis are the most common isolated
bacteria. Amoxicillin (50 mg/kg/day) alone or with clavu-
lanate is the first line antibiotic. Ceftriaxone (50 mg/kg/
day) should be given to children who cannot take oral
medications. Duration of the treatment varies from 10 to
28 days. The antibiotic may be changed if the symptoms
get worse or do not improve within 72 hours (cefixime
8 mg/kg/day) [4-6].
AOM is an inflammatory disease of the middle ear
involving the tympanic cavity frequently caused by
S. pneumoniae, H. influenzae and M. catarrhalis . Diagnos-
tic criteria for AOM are:
• moderate to severe bulging of TM or new onset of
othorrea not due to acute otitis externa;
• mild bulging of the TM and recent onset of ear-
ache or intense erythema of the TM.
Pediatricians should prescribe antibiotics in children
aged <6 months with both severe and moderate presenta-
tions, in children aged between 6 and 24 months with
severe presentation in both unilateral and bilateral AOM
or in those with moderate presentation in bilateral AOM.
Children aged > 24 months need antibiotic therapy
only when the presentation is severe [7,8]. Amoxicillin
(50 mg/kg/day) alone or with clavulanate is the first choice
in moderate and severe presentation respectively. Alterna-
tive initial antibiotics include cefaclor (40-50 mg/kg/day)
and cefuroxime-axetil (30 mg/kg/day) or cefpodoxima-
proxetil (8 mg/kg/day) respectively. Ceftriaxone
(50 mg/kg/day) can be given to children who cannot
take oral medications or when the symptoms do not
improve within 72 hours [9]. The duration of the treat-
ment may vary from 5 to 10 days [8].
Most pharyngitis episodes are caused by viruses. Anti-
biotic therapy is recommended in every child with
microbiologically documented group A b-hemolytic
streptococcus pharyngitis (37%). The first-line treatment
is amoxicillin (50 mg/kg/day for 10 days). In non-
compliant cases, cefaclor (40 mg/kg/day) or cefuroxime-
axetil (20-30 mg/kg/day) may be administrated [10].
Epiglottitis is a supraglottic laryngitis. It may be caused
by S. pneumonia, S. aureus, b-hemolytic streptococcus
and H. influenzae. The priority is airway management
followed by antibiotic (ceftriaxone 50-75 mg/kg/day)
treatment and steroids [11].
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